RecruitingPhase 2NCT06200155

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy


Sponsor

M.D. Anderson Cancer Center

Enrollment

30 participants

Start Date

Apr 16, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy on depression and/or anxiety in participants who are being treated for advanced cancer.


Eligibility

Min Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether psilocybin-assisted psychotherapy (using a single guided dose of psilocybin, the active compound in "magic mushrooms") can help reduce depression, anxiety, or existential distress in people living with advanced, incurable cancer. **You may be eligible if...** - You have been diagnosed with advanced or metastatic cancer that is not curable, including lung, kidney, bladder, prostate, head and neck, ovarian, breast, gastric, cervical, anal, or MSI-high cancers - Your cancer has progressed despite at least one prior standard treatment - Your disease is stable enough for study participation - You have significant psychological distress related to your diagnosis **You may NOT be eligible if...** - Your cancer is early-stage and potentially curable - You have a history of psychosis or conditions that make psilocybin unsafe - You are currently in a mental health crisis - You are taking medications that would interact with psilocybin Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPsilocybin

Given by PO

OTHERNiacin

Given by PO


Locations(1)

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06200155


Related Trials